Company developing novel small molecule protein degraders for intractable diseases
Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” therapeutics, has announced the close of USD6...
Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” therapeutics, has announced the close of USD6...
Oriano gives his views on the negative market sentiments taking a que from the sharp correction from Wall street overnight....
G13 is proud to present MOSAIC, a solo exhibition displaying a series of recent artworks from their renowned abstract painter,...
Despite investors galloping out of the gates to face a brave new year, it was the same old lockdown fear...
Alibaba founder Jack Ma has been absent from public view since late October, including missing the final episode of a...
Jeff shares his views on Asian markets as well as the US election runoff and how he views the positive...
Zurich Malaysia appoints Khoo Ai Lin, who holds a Bachelor of Economics majoring in Banking & Finance from La Trobe...
International market analysis and insights from Stephen Innes, Chief Global Market Strategist at Axi, Focus is completely on the Georgia...
In a special edition of Biztech ASEAN Midday Marketwatch, Jeff and David share their insights on investing and talk about...
By Dr Rais Hussin, President/CEO of EMIR Research, As we take stock of 2020, billionaires as a group did pretty...
We broadcast daily to affluent senior leaders, decision-makers and corporate audiences globally to inform, inspire and share what’s happening in the world of technology and business in Asia Pacific and around the world.
Phone: +60 16-2011 050
Email: editor@biztech.asia
Address:
Level 18, Boutique Office 1 (B01-C)
Menara 2, No. 3, Jalan Bangsar,
KL Eco City, 59200, Kuala Lumpur.
© 2022 Biztech Asia - Powered by Milestones.digital.
© 2022 Biztech Asia - Powered by Milestones.digital.